State Street

State Street’s Decoy Therapeutics DCOY Stock Holding History

State Street’s Portfolio DCOY Stock Details DCOY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4	Closed	-$28K	–	4890
2022 Q3	$28K	Hold	4	–	–	﹤0.01%	4780
2022 Q2	$30K	Hold	4	–	–	﹤0.01%	4818
2022 Q1	$57K	Hold	4	–	–	﹤0.01%	4775
2021 Q4	$71K	Hold	4	–	–	﹤0.01%	4641
2021 Q3	$145K	Hold	4	–	–	﹤0.01%	4461
2021 Q2	$151K	Buy	+4	New	+$178K	﹤0.01%	4279
2017 Q2	–	Hold	0	–	-$612K	–	3726
2017 Q1	–	Hold	0	–	–	–	3354
2016 Q4	–	Hold	0	–	–	–	3339
2016 Q3	–	Hold	0	–	–	–	3055
2016 Q2	–	Hold	0	–	–	–	3205
2016 Q1	–	Hold	0	–	–	–	3329
2015 Q4	–	Hold	0	–	–	–	3335
2015 Q3	–	Hold	0	–	–	–	3352
2015 Q2	–	Hold	0	–	–	–	3322
2015 Q1	–	Hold	0	–	–	–	3460

Other funds holding DCOY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return